In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes ...

The liraglutide injection, which is currently in shortage and sold under the brand name Victoza, will provide a low-cost option for those who need GLP-1 medications. “Generic drugs provide ...

Liraglutide, sold under the brand name Victoza for diabetes ... But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

A few other drugmakers are preparing to enter the GLP-1 market, which remains dominated by Eli Lilly and Novo Nordisk. In June, Teva Pharmaceuticals launched its generic version of Victoza.